查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197137

痔疮治疗设备市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Hemorrhoid Treatment Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

痔疮治疗设备市场预计在预测期内（2022 年至 2027 年）的复合年增长率为 4.7%。

COVID-19 大流行是一个前所未有的健康问题，对世界各地的社区、工业、企业和生计产生了负面影响。 全球越来越多的 COVID-19 病例对市场产生了重大影响。 例如，2020 年 10 月发表的一项题为“COVID-19 检疫对晚期痔疮疾病的影响以及远程医疗在患者管理中的作用”的研究发现，与 COVID-19 相关的延误与痔疮症状和患者健康有关据说会导致恶化。 体重减轻和生活方式的改变是决定疾病严重程度的重要因素。 因此，COVID-19 对市场增长产生了显着影响。

痔疮是肿胀组织内肿胀、扩张的血管异常肿块，发生在肛管内或肛门外，其特征是出血、疼痛和瘙痒。 痔疮形成于直肠内部（内痔）或肛门周围皮肤下（外痔）。 有针对痔疮的有效治疗方法，例如束带固定器和双极探针，但大多数人在家庭治疗和生活方式改变后都会感到宽慰。

此外，研究的增加是推动市场增长的主要因素之一。 例如，2021 年 4 月发表的一项题为“埃塞俄比亚西北部贡德尔大学综合专科医院外科门诊成年患者痔疮患病率及相关因素”的研究发现，痔疮的总体患病率很高。其在男性受试者中的患病率很高。 已发现便秘和超重会增加患痔疮的机率。 卫生专业人员尤其是高危人群更容易进行痔疮早期检测和干预筛查。 因此，越来越多的诊断将导致对治疗的需求增加，这将成为未来市场增长的驱动力。

预计临床试验的增加也将推动市场增长。 例如，一项名为“内镜治疗痔疮的比较研究（METHOD）：一项多中心随机对照临床试验”的临床研究由王方宇发起，于2022年5月开始，2025年1月完成。预计一个月内完成。 检查每种此类设备有效性的研究可能会导致未来在治疗痔疮时使用新设备，这有望推动市场增长。

因此，由于上述因素，市场有望在预测期内出现增长。 然而，多种药物作为替代治疗选择的可用性可能会阻碍未来的市场增长。

痔疮治疗设备的市场趋势

Bundligator有望占据痔疮治疗器械市场主要份额

由于目标疾病负担增加、研究增加以及市场参与者推出新产品，预计在预测期内 Bandligators 将出现增长。 对于内痔和严重的痔疮，Bandligator 在治疗结果和疗效方面提供了一个优越的解决方案。

各种研究证明了该设备在不同阶段的治疗效果，从而加速了绑带钳的采用并促进了细分市场的增长。 例如，在 2021 年 3 月发表的一项题为“橡皮筋结扎与痔切除术治疗 II-III 级痔疮：随机对照试验的系统评价和荟萃分析”的研究中，肛瘘与更好的症状控制相关。但以更多的疼痛和并发症为代价。 对于 II-III 级痔疮患者，痔切除术比橡皮筋结扎术能更好地控制症状，但术后疼痛和并发症更多。 像这样的研究已经证明，橡皮筋结扎手术比其他仪器具有更少的并发症，这正在促进该领域的发展。

此外，产品发布也有望推动该细分市场的增长。 例如，2020 年 8 月，Micro-Tech Endoscopy USA 推出了 In-Sight Multi-Band Ligator，这是其止血产品组合中的一款新产品。 In-Sight 专为 I、II 和 III 级内痔的门诊非内窥镜治疗而设计。 此类产品的推出预计将推动该细分市场的增长。

因此，由于上述因素，该市场有望在预测期内呈现增长。

预计北美将占据很大的市场份额，预计在预测期内也会如此

北美有望在痔疮治疗设备市场占据重要市场份额，因为该地区对先进治疗方案的可用性、更好的报销政策以及新产品的快速商业化的认识不断提高。.

根据 2021 年 4 月发表的一篇题为“埃塞俄比亚西北部贡德尔大学综合专科医院外科门诊成年患者痔疮的患病率和相关因素”的 PLOS ONE 期刊文章，痔疮在美国很普遍据报导，它是第四大最常见的门诊胃肠道诊断，约有 330 万门诊就诊。 如此高的疾病负担预计将推动该地区的市场增长。

此外，绷带结扎术是该地区治疗出血性内痔疾病最常用的方法之一。 这些设备的产品发布一直是推动市场增长的因素之一。 例如，2020 年 3 月，Micro-Tech Endoscopy 为其止血产品组合推出了一款新产品 In-Sight Multi-Band Ligator。 In-Sight 专为 I、II 和 III 级内痔的门诊非内窥镜治疗而设计。

此外，多项研究强调这些方法使用起来是安全的。 例如，2020 年 2 月，一项名为“橡皮筋结扎术对出血性内痔的影响”的临床试验，旨在检验橡皮筋结扎术的效果。 本研究的目的是检查在使用抗痔疮药物治疗的出血性内痔中加入橡皮筋结扎术的有效性。 预计此类研究将推动市场的增长。 此外，痔疮治疗设备的技术进步和完善的医疗基础设施为该地区市场的增长做出了重大贡献。

因此，由于上述因素，预计北美地区的市场在预测期内将出现增长。

痔疮治疗器械市场竞争者分析

痔疮治疗设备市场是分散的，由几家主要参与者组成。 从市场份额的角度来看，一些主要参与者主导着市场。 目前主导市场的公司包括 Boston Scientific Corporation、Medtronic Plc、Cook Medical、DePuy Synthes (Johnson & Johnson)、Integra LifeSciences Corporation、CONMED Corporation、Medline Industries, Inc、Surkon Medical、Sklar Surgical Instruments 和 Privi Medical。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 痔疮患病率上升
    • 痔疮治疗设备技术进展
  • 市场製约因素
    • 多种药物作为替代治疗方案的可能性
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品类型
    • 绑匪
    • 双极探头
    • 激光探头
    • 冷冻治疗设备
    • 红外凝固器
    • 硬化剂注射器
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • A.M.I. GmbH
    • Boston Scientific Corporation
    • CONMED Corporation
    • Cook Medical
    • DePuy Synthes（Johnson & Johnson）
    • Integra LifeSciences Corporation
    • Medline Industries, Inc
    • Medtronic Plc
    • obp Surgical Corporation
    • Privi Medical
    • Sklar Surgical Instruments
    • Surkon Medical Co., Ltd

第7章 市场机会与今后动向

简介目录
Product Code: 68008

The hemorrhoid treatment devices market is expected to register a CAGR of 4.7% during the forecast period (2022-2027).

The COVID-19 pandemic was an unprecedented health concern and adversely affected communities, industries, businesses, and lives worldwide. The rising COVID-19 cases across the globe have had a profound impact on the market. For instance, a research study titled "Impact of COVID-19 Quarantine on Advanced Hemorrhoidal Disease and the Role of Telemedicine in Patient Management", published in October 2020, stated that COVID-19-related delays are linked to a deterioration of hemorrhoidal symptoms and patients' well-being. Weight loss and lifestyle changes were deemed critical factors in determining disease severity. Thus, COVID-19 had a pronounced impact on the growth of the market.

A hemorrhoid is an abnormal mass of engorged and dilated blood vessels in swollen tissue that occurs internally in the anal canal or externally around the anus that may be characterized by bleeding, pain, or itching. Hemorrhoids can develop inside the rectum (internal hemorrhoids) or under the skin around the anus (external hemorrhoids). Some effective treatment options, such as band ligators and bipolar probes, are available for hemorrhoids, but most people get relief with home treatments and lifestyle changes.

Moreover, the growing number of research studies is one of the major factors driving the growth of the market. For instance, a research study titled "Prevalence and associated factors of hemorrhoids among adult patients visiting the surgical outpatient department in the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia" published in April 2021 stated that the overall prevalence of hemorrhoids was high, and its prevalence was higher in male subjects. Constipation and being overweight were found to increase the odds of having hemorrhoids. Screening for early identification and intervention of hemorrhoids, especially for high-risk groups, is better practiced by health professionals. Hence, the increasing diagnosis will lead to an increase in demand for treatment and thus drive market growth in the future.

The increasing number of clinical trials is also expected to propel the growth of the market. For instance, the clinical study titled "Comparative Study on Endoscopic Treatments for Hemorrhoids (METHOD): a Multicenter, Randomized Controlled Clinical Trial" was started in May 2022 and is expected to be completed by January 2025, sponsored by Fangyu Wang. Such studies to find out the effectiveness of the different devices may lead to the usage of new devices in the treatment of hemorrhoids in the future and thus are expected to impel the growth of the market.

Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period. However, the availability of several drugs as alternate treatment options will hinder market growth in the future.

Hemorrhoid Treatment Devices Market Trends

Band Ligators Segment is Expected to Hold a Major Market Share in the Hemorrhoid Treatment Devices Market

The band ligators segment is expected to show growth over the forecast period, owing to the rising burden of target disease, increasing research studies, and the launch of newer products by the market players. For internal and severe forms of hemorrhoids, band ligators offer better solutions than others in terms of outcomes and effectiveness in treatment.

Various research studies demonstrate the effectiveness of treatment with devices at different stages, thereby accelerating the adoption of band ligators and thus contributing to the growth of the market segment. For instance, a research study titled "Rubber band ligation versus haemorrhoidectomy for the treatment of grade II-III hemorrhoids: a systematic review and meta-analysis of randomized controlled trials" published in March 2021 stated that haemorrhoidectomy seems to provide better symptom control but at the cost of more pain and complications. Hemorrhoidectomy offers better symptom control than rubber band ligation in patients with grade II-III hemorrhoids but is accompanied by more postoperative pain and complications. Such studies demonstrate fewer complications associated with band ligators than with other devices, in turn fueling the segment's growth.

Furthermore, the launch of the products is also expected to propel the growth of the market segment. For instance, in August 2020, Micro-Tech Endoscopy USA launched a new product in its hemostasis portfolio, namely the In-Sight Multi-Band Ligator. In-Sight was designed for the office-based, non-endoscopic treatment of grade I, II, and III internal hemorrhoids. Such launches are expected to propel the growth of the segment.

Thus, owing to the abovementioned factors, the market segment is expected to show growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the hemorrhoid treatment devices market due to increasing awareness about the availability of advanced treatment options, better reimbursement policies, and faster commercialization of novel products in this region.

According to the PLOS ONE Journal article titled "Prevalence and associated factors of hemorrhoids among adult patients visiting the surgical outpatient department in the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia" published in April 2021, reported that in the United States, hemorrhoid disease is the fourth leading outpatient gastrointestinal diagnosis, accounting for nearly 3.3 million ambulatory care visits. Such a high burden of diseases is expected to drive the growth of the market in the region.

Additionally, band ligation is one of the most frequently used methods in treating hemorrhagic internal hemorrhoidal disease in the region. Product launches with respect to these devices are one of the factors driving the growth of the market. For instance, in March 2020, Micro-Tech Endoscopy launched a new product in their hemostasis portfolio with the In-Sight Multi-Band Ligator. In-Sight was designed for the office-based, non-endoscopic treatment of grade I, II, and III internal hemorrhoids.

Furthermore, several studies have highlighted that these methods are safe to use. For instance, in February 2020, a clinical trial titled "The Effect of Rubber Band Ligation in Bleeding Internal Hemorrhoids" studied the effect of rubber band ligation. Under this, the investigators aimed to investigate the benefit of adding rubber band ligation to treatment in hemorrhagic internal hemorrhoidal disease treated with the anti-hemorrhoidal drug. Such studies are expected to propel the growth of the market. Moreover, technological advancements in hemorrhoid treatment devices and well-established healthcare infrastructure are also considerably fueling the regional market's growth.

Thus, owing to the abovementioned factors, the studied market in the North American region is expected to show growth over the forecast period.

Hemorrhoid Treatment Devices Market Competitor Analysis

The Hemorrhoid Treatment Devices Market is fragmented and consists of several major players. In terms of market share, a few major players dominate the market. Some companies currently dominating the market are Boston Scientific Corporation, Medtronic Plc, Cook Medical, DePuy Synthes (Johnson & Johnson), Integra LifeSciences Corporation, CONMED Corporation, Medline Industries, Inc, Surkon Medical Co., Ltd, Sklar Surgical Instruments, and Privi Medical.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Prevalence of Hemorrhoids
    • 4.2.2 Technological Advancements in Hemorrhoid Treatment Devices
  • 4.3 Market Restraints
    • 4.3.1 Availability of Several Drugs as an Alternate Treatment Option
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Band Ligators
    • 5.1.2 Bipolar Probes
    • 5.1.3 Laser Probes
    • 5.1.4 Cryotherapy Devices
    • 5.1.5 Infrared Coagulators
    • 5.1.6 Sclerotherapy Injectors
    • 5.1.7 Others
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle-East
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle-East
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 A.M.I. GmbH
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 CONMED Corporation
    • 6.1.4 Cook Medical
    • 6.1.5 DePuy Synthes (Johnson & Johnson)
    • 6.1.6 Integra LifeSciences Corporation
    • 6.1.7 Medline Industries, Inc
    • 6.1.8 Medtronic Plc
    • 6.1.9 obp Surgical Corporation
    • 6.1.10 Privi Medical
    • 6.1.11 Sklar Surgical Instruments
    • 6.1.12 Surkon Medical Co., Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS